<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The activation of N-<z:chebi fb="36" ids="29309">methyl</z:chebi>-d-<z:chebi fb="0" ids="29995">aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptors by excessive release of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> is involved in the pathogenesis of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Thus the <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor has become an attractive therapeutic target for the development of neuroprotectants, especially from <z:chebi fb="68" ids="48706">antagonists</z:chebi> with moderate to low affinity </plain></SENT>
<SENT sid="2" pm="."><plain>In the current study, <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor blockage and neuroprotective effects of bis(12)-hupyridone (B12H), a novel dimeric <z:chebi fb="0" ids="38462">acetylcholinesterase inhibitor</z:chebi> derived from a naturally occurring monomeric analog huperzine A, were investigated in vitro and in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>In primary rat cerebellar granule neurons, B12H (0.1 nM to 1 μM) prevented <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a concentration- and time-dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain>Receptor-ligand binding analysis showed that B12H competed with [(3)H]MK801 with a K(i) value of 7.7 μM </plain></SENT>
<SENT sid="5" pm="."><plain>In the 2-hour middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> rat model, B12H (0.4 and 0.8 mg/kg, 30 min before-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and 15 min post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, i.p.) significantly attenuated <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the penumbra region, improved neurological behavior impairment, and decreased cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> and neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the <z:hpo ids='HP_0001297'>stroke</z:hpo> model </plain></SENT>
<SENT sid="6" pm="."><plain>Together, these results showed that B12H moderately blocks <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors at MK801 site and exerts neuroprotection against excitotoxic and ischemic insults in vitro and in vivo </plain></SENT>
<SENT sid="7" pm="."><plain>Combined with our previous publications, we conjecture that B12H might exert neuroprotection via acting on multiple targets </plain></SENT>
</text></document>